Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Gambro

- PMLiVE

Baxter plans to file long-acting Advate in EU next year

Patients experienced a 95% reduction in bleeds

- PMLiVE

Medical device M&A hit ‘all-time high’ in 2014

Deals last year were led by Medtronic’s acquisition of Covidien

- PMLiVE

FDA approves Baxter drug for rare form of haemophilia

Obizur is derived from pig proteins

- PMLiVE

Baxter to launch HyQvia in US next week

The PID drug has been used in Europe for over a year

- PMLiVE

Baxter names biopharma spin-off Baxalta

Will separate from medical technology business

- PMLiVE

Baxter ‘will file long-acting haemophilia drug by year-end’

New version of Advate clears late-stage trial

- PMLiVE

Baxter opens Advate facility in Singapore

Follows EU approval for haemophilia A drug plant

- PMLiVE

Pfizer acquires Baxter Men C and encephalitis vaccines for $635m

Snaps up marketed vaccines and part of Baxter's Austrian manufacturing plant

Baxter reshuffles financial heads

Names CFOs for biotech spin-off and 'new' Baxter

- PMLiVE

Baxter splits in two, spinning off biotech business

The 'new' Baxter will focus on medical products

- PMLiVE

Baxter re-files HyQvia for immunodeficiency in US

Pharma company provides FDA with more data

- PMLiVE

Baxter licenses cancer drug from CTI in $172m deal

Pacritinib is being investigated to treat blood disorder myelofibrosis

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links